FDA Approval for BIOTRONIK’s Prospera™ Spinal Cord Stimulation System
Global Leader in Cardiac Rhythm Technology Solutions Expands Therapies for the Treatment of Chronic Intractable Pain with a New Approach to Managing Spinal Cord Stimulation
Global Leader in Cardiac Rhythm Technology Solutions Expands Therapies for the Treatment of Chronic Intractable Pain with a New Approach to Managing Spinal Cord Stimulation
Berlin/Singapore (April 14, 2023)
Berlin, Germany and Zurich, Switzerland – April 12, 2023
New investors, Andera Partners and Earlybird Venture Capital, join existing investor, Pureos Bioventures raising an additional EUR 22.75 million
Funds will be used to advance clinical pipeline and further build Ariceum Therapeutics
Olivier Litzka…
Be prepared to learn new things constantly
Deadline: May 1st, 2023
BREAKTHROUGH RESEARCH WAS AND IS THE KEY TO UNDERSTANDING AND SOLVING THE GREATEST CHALLENGES OF OUR TIME
“Ultimately, the goal is to bring health-innovations Made in Europe to the marketplace.”
Large-scale study shows that DX-ICD systems together with Home Monitoring allow for reliable guideline-recommended monitoring of subclinical AF
Genes are not the only drivers of evolution. The iconic fins of skates are caused by changes in the non-coding parts of the genome and its three-dimensional structure, a research team including Darío Lupiáñez at the Max Delbrück Center reports in…
Berlin, 12 April 2023 – Eckert & Ziegler’s fully owned subsidiary Qi Kang Medical Technology Ltd. (QKM) has recently received the authorization for its Environmental Impact Assessment (EIA) from the Department of Ecology and Environment of Jiangsu…